Failure site | Total group (n = 210) n (%) | Non-DLI group (n = 165) n (%) | DLI group (n = 45) n (%) | P |
---|---|---|---|---|
Distant metastasis | 52(24.8) | 32(19.4) | 20(44.4) |  < 0.001 |
 External iliac lymph node | 7(3.3) | 5(3.0) | 2(4.4) | 0.996 |
 Inguinal lymph node | 10(4.8) | 5(3.0) | 5(11.1) | 0.024 |
 Retroperitoneal lymph node | 10(4.8) | 5(3.0) | 5(11.1) | 0.024 |
 Common iliac lymph nodes | 2(1.0) | 2(1.2) | 0(0.0) | 0.902 |
 Lungs | 32(15.2) | 19(11.5) | 13(28.9) | 0.004 |
 Liver | 13(6.2) | 8(4.8) | 5(11.1) | 0.122 |
 Bone | 12(5.7) | 6(3.6) | 6(13.3) | 0.013 |
 Brain | 4(1.9) | 2(1.2) | 2(4.4) | 0.426 |
 Peritoneum | 2(1.0) | 1(0.6) | 1(2.2) | 0.900 |
 Adrenal gland | 2(1.0) | 1(0.6) | 1(2.2) | 0.900 |
 Ovary | 1(0.5) | 0(0.0) | 1(2.2) | 0.214 |
 Pleura | 1(0.5) | 1(0.6) | 0(0.0) | 1.000 |
 Left supraclavicular lymph node | 3(1.4) | 2(1.2) | 1(2.2) | 0.840 |
 Mediastinal lymph nodes | 4(1.9) | 2(1.2) | 2(4.4) | 0.426 |
 Pericardium | 1(0.5) | 0(0.0) | 1(2.2) | 0.214 |
 Pancreas | 1(0.5) | 1(0.6) | 0(0.0) | 1.000 |
 Other sites | 3(1.4) | 3(1.8) | 0(0.0) | 0.840 |
 Unknow | 3(1.4) | 2(1.2) | 1(2.2) | - |
Locoregional recurrence | 19(9.0) | 13(7.9) | 6(13.3) | 0.729 |
 Anterior pelvic subsite | 7(3.3) | 4(2.4) | 3(6.7) | 0.349 |
 Posterior pelvic subsite | 3(1.4) | 3(1.8) | 0(0.0) | 0.840 |
 Lateral pelvic subsite | 6(2.9) | 3(1.8) | 3(6.7) | 0.220 |
 Inferior pelvic subsite | 3(1.4) | 2(1.2) | 1(2.2) | 0.840 |
 Surgical anastomotic subsite | 2(1.0) | 2(1.2) | 0(0.0) | 0.902 |